2 Result: Theratechnologies
Revised Outlook: Theratechnologies and AngioDynamics Fall Short
July 12th, 2023
Theratechnologies Inc. (Nasdaq: THTX) reported second-quarter fiscal 2023 revenue of $17.549 million, falling short of the consensus estimate of $20.32 million. The company attributes this lower-than-expected revenue to specialty pharmacy inventory a. Read more
Earnings Preview: MillerKnoll, AngioDynamics, and Theratechnologies
July 09th, 2023
On Wednesday, July 12, several companies are expected to report their financial results, including: MillerKnoll, Inc. (Nasdaq: MLKN), a consumer goods company, is set to release its financial results for the fourth quarter and full-year fiscal 202. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
February 27th, 2026February 26th, 2026
Member Login